Mechanisms for aldosterone and spironolactone-induced positive inotropic actions in the rat heart

Hypertension

Volumn 44, Issue 5, 2004, Pages 751-757

  Barbato, John C ^a   Rashid, Sumia ^a   Mulrow, Patrick J ^a   Shapiro, Joseph I ^a   Franco Saenz, Roberto ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Calcium; Cardiac function; Heart failure; Mineralocorticoid

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ADENOSINE TRIPHOSPHATASE; ALDOSTERONE; DACTINOMYCIN; MINERALOCORTICOID ANTAGONIST; MYOSIN; PHOSPHATE; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN; SPIRONOLACTONE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLE; ENZYME ACTIVITY; HEART CONTRACTION; HEART MUSCLE CELL; HORMONAL REGULATION; INOTROPISM; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SYSTOLE;

ADENOSINE TRIPHOSPHATASES; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; CALCIUM; CELLS, CULTURED; HEART; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; POTASSIUM; RATS; RATS, INBRED WKY; SPIRONOLACTONE; STIMULATION, CHEMICAL;

EID: 7244243797     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000144466.11568.7e     Document Type: Article

References (54)

1. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol. 1996;78:902-907.
2. Funder J. Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol. 2001;28:1002-1006.
3. Fujisawa G, Dilley R, Fullerton MJ, Funder JW. Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration. Endocrinology. 2001;142:3625-3631.
4. Young M, Funder JW. Aldosterone and the heart. Trends Endocrinol Metab. 2000;11:224-226.
5. Funder JW. Aldosterone, salt and cardiac fibrosis. Clin Exp Hypertens. 1997;19:885-899.
6. Barbato JC, Mulrow PJ, Shapiro JI, Franco-Saenz R. Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension. 2002;40:130-135.
7. Tanz RD. Studies on the inotropic action of aldosterone on isolated cardiac tissue preparations; including the effects of pH, ouabain and SC-8109. J Pharmacol Exp Ther. 1962;135:71-78.
8. Tanz RD. Inotropic Effects of Certain Steroids Upon Heart Muscle. Rev Can Biol. 1963;22:147-163.
9. Wehling M, Kasmayr J, Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? Am J Physiol. 1991;260:E719-E726.
10. Wehling M, Eisen C, Christ M. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Mol Cell Endocrinol. 1992;90:C5-C9.
11. Wehling M, Christ M, Theisen K. Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol. 1992;263:E974-E979.
12. Wehling M, Christ M, Gerzer R. Aldosterone-specific membrane receptors and related rapid, non-genomic effects. Trends Pharmacol Sci. 1993;14:1-4.
13. Gekle M, Silbernagl S, Wunsch S. Non-genomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells. J Physiol. 1998:511(Pt 1):255-263.
14. Manegold JC, Falkenstein E, Wehling M, Christ M. Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol (Noisy-le-grand). 1999;45:805-813.
15. Ebata S, Muto S, Okada K, Nemoto J, Amemiya M, Saito T, Asano Y. Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 1999;56:1400-1412.
16. Passaquin AC, Lhote P, Ruegg UT. Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol. 1998;124:1751-1759.
17. Alzamora R, Michea L, Marusic ET. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 2000;35:1099-1104.
18. Wehling M, Bauer MM, Ulsenheimer A, Schneider M, Neylon CB, Christ M. Nongenomic effects of aldosterone on intracellular pH in vascular smooth muscle cells. Biochem Biophys Res Commun. 1996;223:181-186.
19. Winter DC, Schneider MF, O'Sullivan GC, Harvey BJ, Geibel JP. Rapid effects of aldosterone on sodium-hydrogen exchange in isolated colonic crypts. J Membr Biol. 1999;170:17-26.
20. Doolan CM, Harvey BJ. Modulation of cytosolic protein kinase C and calcium ion activity by steroid hormones in rat distal colon. J Biol Chem. 1996;271:8763-8767.
21. Urbach V, Harvey BJ. Rapid and non-genomic reduction of intracellular [Ca(2+)] induced by aldosterone in human bronchial epithelium. J Physiol. 2001;537:267-275.
22. Doolan CM, Condliffe SB, Harvey BJ. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and (Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br J Pharmacol. 2000;129:1375-1386.
23. Harvey BJ, Higgins M. Nongenomic effects of aldosterone on Ca2+ in M-1 cortical collecting duct cells. Kidney Int. 2000;57:1395-1403.
24. Doolan CM, O'Sullivan GC, Harvey BJ. Rapid effects of corticosteroids on cytosolic protein kinase C and intracellular calcium concentration in human distal colon. Mol Cell Endocrinol. 1998;138:71-79.
25. Doolan CM, Harvey BJ. Rapid effects of steroid hormones on free intracellular calcium in T84 colonic epithelial cells. Am J Physiol. 1996;271:C1935-C1941.
26. Sato A, Liu JP, Funder JW. Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro. Endocrinology. 1997;138:3410-3416.
27. Young M, Funder J. Mineralocorticoid action and sodium-hydrogen exchange: studies in experimental cardiac fibrosis. Endocrinology. 2003;144:3848-3851.
28. Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z. Shapiro JI. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol. 2003;14:90-97.
29. Periyasamy SM, Chen J, Cooney D, Carter P, Omran E, Tian J, Priyadarshi S, Bagrov A, Fedorova O, Malhotra D, Xie Z, Shapiro JI. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int. 2001;60:2367-2376.
30. Chen J, Feller GM, Barbato JC. Periyasamy S, Xie ZJ, Koch LG, Shapiro JI, Britton SL. Cardiac performance in inbred rat genetic models of low and high running capacity. J Physiol. 2001;535:611-617.
31. Priyadarshi S, Valentine B, Han C, Fedorova OV, Bagrov AY, Liu J, Periyasamy SM, Kennedy D, Malhotra D, Xie Z, Shapiro JI. Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int. 2003;63:1785-1790.
32. Piacentino V 3rd, Weber CR. Chen X, Weisser-Thomas J, Margulies KB, Bers DM, Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res. 2003;92:651-658.
33. Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem. 2000;275:27838-27844.
34. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:2210-2218.
35. Solaro RJ, Pang DC, Briggs FN. The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta. 1971;245:259-262.
36. Fabiato A. Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol. 1981;78:457-497.
37. Rarick HM, Opgenorth TJ, von Geldern TW, Wu-Wong JR, Solaro RJ. An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity. J Biol Chem. 1996;271:27039-27043.
38. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375-400.
39. Tashima Y. Removal of protein interference in the Fiske-Subbarow method by sodium dodecyl sulfate. Anal Biochem. 1975;69:410-414.
40. Barbato JC, Koch LG, Darvish A, Cicila GT, Melting PJ, Britton SL. Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J Appl Physiol. 1998;85:530-536.
41. Harvey BJ, Doolan CM, Condliffe SB. Renard C, Alzamora R, Urbach V. Non-genomic convergent and divergent signalling of rapid responses to aldosterone and estradiol in mammalian colon. Steroids. 2002;67:483-491.
42. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther. 2001;15:79-87.
43. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation. 2003;108:1831-1838.
44. Quaschning T, Ruschitzka F, Niggli B, Lunt CM, Shaw S, Christ M. Wehling M, Luscher TF. Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension. Nephrol Dial Transplant. 2001;16:2146-2151.
45. Koppel H, Christ M, Yard BA, Bar PC, van der Woude FJ, Wehling M. Nongenomic effects of aldosterone on human renal cells. J Clin Endocrinol Metab. 2003;88:1297-1302.
46. Christ M, Wehling M. Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells. Steroids. 1999;64:35-41.
47. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ Res. 1995;76:973-979.
48. Christ M, Eisen C, Aktas J, Theisen K, Wehling M. The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes. J Clin Endocrinol Metab. 1993;77:1452-1457.
49. Wehling M, Kasmayr J, Theisen K. Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro. Cell Calcium. 1990;11:565-571.
50. Maguire D, MacNamara B, Cuffe JE, Winter D, Doolan CM, Urbach V, O'Sullivan GC, Harvey BJ. Rapid responses to aldosterone in human distal colon. Steroids. 1999;64:51-63.
51. Rehring TF, Shapiro JI, Cain BS, Meldrum DR, Cleveland JC, Harken AH, Banerjee A. Mechanisms of pH preservation during global ischemia in preconditioned rat heart: roles for PKC and NHE. Am J Physiol. 1998;275:H805-H813.
52. Matsui H, Barry WH, Livsey C, Spitzer KW. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215-221.
53. Xie Z, Kometiani P, Liu J, Li J, Shapiro JI, Askari A. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem. 1999;274:19323-19328.
54. Caballero R. Moreno I, Gonzalez T, Arias C, Valenzuela C, Delpon E, Tamargo J. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels. Circulation. 2003;107:889-895.